Jean-Yves Ravinet, 56, graduated from Paris-Grignon Institut National Agronomique, was previously Head of the Europe, Middle East and Africa region for the crop protection business of the Japanese Sumitomo Chemical Group.
Jean-Yves Ravinet started his career at Rhône-Poulenc Agro in France. He successively managed several European subsidiaries (Turkey, Benelux/Scandinavia, Spain) and then the Asia-Pacific region. When Aventis Crop Science was created, he led the Latin America operations. He later was in charge of synthesis intermediates for agrochemicals and pharmaceuticals at Rhodia Life Science Systems.
His knowledge of agriculture and of regulated industries, a long practice of launches and product life cycle management and a robust experience of international development will be valuable assets for the Vétoquinol Group.
Jean-Yves Ravinet is based in the Lure Headquarter of the Group.
“We are delighted to have Jean-Yves Ravinet joining us at Vétoquinol and strengthening our management team,” Group CEO Matthieu Frechin affirmed.”His extensive and international experience in a sector that has much in common with the animal health sector will be a real asset for Vétoquinol.”
About Vétoquinol
Vétoquinol is a leading global player in the animal health sector serving both the livestock (cattle and pigs) and pet (dogs and cats) markets.
An independent pure player, Vétoquinol designs, develops and sells veterinary drugs and non-medicinal products in Europe, the Americas and the Asia Pacific region.
Since its foundation in 1933, Vétoquinol has pursued a strategy combining innovation with geographical diversification. The Group’s hybrid growth is driven by the reinforcement of its product portfolio coupled with acquisitions in high potential growth markets. Vétoquinol employs over 1,800 people.
Vétoquinol has been listed on NYSE Euronext Paris since 2006 (symbol: VETO).
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
